Evidence map›Paper›PMID 28186720›Full record

ArticleBiochemistry2017

Cuprizone Intoxication Induces Cell Intrinsic Alterations in Oligodendrocyte Metabolism Independent of Copper Chelation.

Alexandra Taraboletti, Tia Walker, Robin Avila, He Huang, Joel Caporoso, Erendra Manandhar, Thomas C Leeper, David A Modarelli, Satish Medicetty, Leah P Shriver

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 45 citations in OpenAlex.

  1. Cell-specific isotope labeling identifiesbioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. CNS Resident Innate Immune Cells: Guardians of CNS Homeostasis.International journal of molecular sciences · 2024
    Review
  8. Article
  9. How to Use the Cuprizone Model to Study De- and Remyelination.International journal of molecular sciences · 2024
    Review
  10. Astrocytes: Lessons Learned from the Cuprizone Model.International journal of molecular sciences · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. Dysregulated copper transport in multiple sclerosis may cause demyelination via astrocytes.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Ferroptosis Mediates Cuprizone-Induced Loss of Oligodendrocytes and Demyelination.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Alexandra TarabolettiDepartment of Chemistry, University of Akron , Akron, Ohio 44325, United States.ORCID 0000-0002-8779-483X
Tia WalkerDepartment of Chemistry, Indiana University Northwest , Gary, Indiana 46408, United States.
Robin AvilaRenovo Neural, Inc. , Cleveland, Ohio 44106, United States.
He HuangDepartment of Chemistry, University of Akron , Akron, Ohio 44325, United States.
Joel CaporosoDepartment of Anesthesiology, University of Pittsburgh School of Medicine , Pittsburgh, Pennsylvania 15260, United States.
Erendra ManandharDepartment of Chemistry, University of Akron , Akron, Ohio 44325, United States.
Thomas C LeeperDepartment of Chemistry, College of Wooster , Wooster, Ohio 44691, United States.
David A ModarelliDepartment of Chemistry, University of Akron , Akron, Ohio 44325, United States.
Satish MedicettyRenovo Neural, Inc. , Cleveland, Ohio 44106, United States.
Leah P ShriverDepartment of Chemistry, University of Akron , Akron, Ohio 44325, United States.
University of Akron · USCollege of Wooster · USIndiana University Northwest · USUniversity of Pittsburgh · US

Funding

Metabolic and Chemical Analyses of Cuprizone ToxicityR15GM119074 · NIGMS · UNIVERSITY OF AKRON · PI SHRIVER, LEAH PIER · 2016 to 2016
$469k
NIGMS NIH HHS R15 GM119074
6 · The paper itself

Abstract

Cuprizone intoxication is a common animal model used to test myelin regenerative therapies for the treatment of diseases such as multiple sclerosis. Mice fed this copper chelator develop reversible, region-specific oligodendrocyte loss and demyelination. While the cellular changes influencing the demyelinating process have been explored in this model, there is no consensus about the biochemical mechanisms of toxicity in oligodendrocytes and about whether this damage arises from the chelation of copper in vivo. Here we have identified an oligodendroglial cell line that displays sensitivity to cuprizone toxicity and performed global metabolomic profiling to determine biochemical pathways altered by this treatment. We link these changes with alterations in brain metabolism in mice fed cuprizone for 2 and 6 weeks. We find that cuprizone induces widespread changes in one-carbon and amino acid metabolism as well as alterations in small molecules that are important for energy generation. We used mass spectrometry to examine chemical interactions that are important for copper chelation and toxicity. Our results indicate that cuprizone induces global perturbations in cellular metabolism that may be independent of its copper chelating ability and potentially related to its interactions with pyridoxal 5'-phosphate, a coenzyme essential for amino acid metabolism.

Indexed as

Amino AcidsAnimalsBrainBrain ChemistryCell LineChelating AgentsCopperCuprizoneDemyelinating DiseasesDisease Models, AnimalEnergy MetabolismMaleMetabolomeMiceMice, Inbred C57BLMultiple SclerosisAmino AcidsChelating AgentsCopperCuprizonePyridoxal Phosphate

Identifiers

PMID28186720
PMCPMC6145805
OpenAlexW2587417229

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.